Topic: AML treatment options

Objectives: Discuss incorporating Gilteritinib and Quizartinib

Speaker: Dr. Liz Cull, Dr. Bhumika Patel

 

Session date: 
09/25/2024 - 8:00am to 9:00am EDT
Location: 
GMH Support Tower 41/Teams
United States
  • 1.00 ABPath MOC I (Accredited CME)
    This live activity is eligible to be reported to ABPath I as Lifelong Learning per session. The University of South Carolina School of Medicine Greenville is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Please login or register to take this course.